6OP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 3.158 EUR -5.22%

Market Cap: €68.8m

	OSE Immunotherapeutics SA F:6OP	FR
M	M&T Bank Corp DUS:MTZ	US
	Kurita Water Industries Ltd TSE:6370	JP
B	Brown-Forman Corp DUS:BF5B	US
B	Barrick Gold Corp DUS:ABR	CA
U	Unilever PLC AEX:UNA	UK
	China Telecom Corp Ltd F:ZCH	CN
	Grab Holdings Ltd F:A6I	SG
	Harmony Gold Mining Company Ltd F:HAM1	ZA
C	Christian Dior SE DUS:DIO	FR
C	Chorus Ltd ASX:CNU	NZ

Profitability Summary

OSE Immunotherapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 592%

Negative 3Y Average Operating Margin

-667%

Declining Operating Margin

-100% > -1 592%

Negative Net Margin

-1 570%

Negative 3Y Average Net Margin

-654%

Declining Net Margin

-97% > -1 570%

Negative Free Cash Flow Margin

-1 679%

Negative 3Y Average Free Cash Flow Margin

-647%

Declining Free Cash Flow Margin

-101% > -1 679%

Negative ROE

-53%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.